FormaPath to unveil new product at upcoming annual meeting of pathologists

12 Mar 2024
Lab automation developer will exhibit and present a poster at the conference
ITHACA, N.Y., March 12, 2024 /PRNewswire/ -- FormaPath is excited to return to the United States and Canadian Academy of Pathology Annual Meeting for 2024.
The company is exhibiting with a booth (#208) that will offer an exclusive preview of their new, state-of-the-art, lab automation equipment.
Meeting attendees will also be able to view demonstrations of AdiPress, the automated lymph node dissection tool.
On tuesday, March 26 at 9:30 AM the company will participate in a poster presentation: Current State of Intra-/Interobserver Accuracy and Reproducibility in Tissue Biopsy Grossing and Comparison to an Automated Vision System (Poster Board #198)
About FormaPath:
FormaPath is working to revolutionize the cancer staging process through cutting-edge laboratory automation equipment. We are dedicated to improving patient care by streamlining and automating the diagnostic process. Our equipment minimizes human errors, allowing for rapid and accurate sample processing, reducing turnaround times, and increasing efficiency.
With a commitment to research and innovation, we continuously develop state-of-the-art solutions, empowering healthcare professionals to make informed decisions and provide each cancer patient with their best chance at a positive outcome.
To learn more about FormaPath, visit formapath.com.
Contact:
Phil Lonsdale
Commercial Strategy, FormaPath
[email protected]
SOURCE FormaPath
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.